Wednesday, August 31, 2016 10:04:39 AM
https://www.fbi.gov/contact-us/field-offices/sandiego/news/press-releases/ansun-biopharma-to-pay-more-than-2-million-for-overbilling-the-u.s
Ansun used to be known as NexBio...
http://www.sandiegouniontribune.com/news/2011/aug/04/feds-raid-san-diego-vaccine-developer/
So after 11 years NNVC has no actual fraud...other that the repetitive baseless accusations from anonymous posters...and the argument is that Ansun (formerly NexBio) is the example of the integrity given For a biopharma...and after two raids by the FBI (you do realize FBI raids only occur after probable cause has been established under the authority of a United States Attorney) and prosecution handled by the United States Attorney's Office...the only thing Ansun seems to be really good at is being raided by the FBI and getting tens of millions of dollar in NIH grants....you see integrity...I see the fleecing of the American taxpayer...all this within the space of a few years...looks more like a story for 60 minutes...congrats! I think you've finally uncovered the fraud you've been warning us about...IMO you should vigorously peruse it...and thanks for bringing it to our attention.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM